Although there is bipartisan support for drug pricing reform and recent bills introduced in the House and the Senate share some concepts, conservatives and pharmaceutical manufacturers have found plenty to dislike about the drug pricing legislation unveiled last month by House Speaker Nancy Pelosi (D-Calif.).
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.